During the past decade, Grossmont Center For Clinical Research conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 23 clinical trials were completed, i.e. on average, 74.2% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 20 clinical trials were completed. i.e. 105.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Grossmont Center For Clinical Research" #1 sponsor was "Allergan" with 5 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Pfizer" with 4 trials sponsored, "Bayer" with 3 trials sponsored and "Curatek Pharmaceuticals, LLC" with 3 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Grossmont Center For Clinical Research" #1 collaborator was "Allergan Sales, LLC" with 2 trials as a collaborator, "CureVac" with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator, "Registrat-Mapi" with 1 trials as a collaborator and "ResearchPoint Global" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Grossmont Center For Clinical Research" are "Episodic Migraine" (4 trials), "Overactive Bladder" (3 trials), "Vaginal Infection" (3 trials), "Hot Flashes" (2 trials) and "Irritable Bowel Syndrome Characterized by Constipation" (2 trials). Many other conditions were trialed in "Grossmont Center For Clinical Research" in a lesser frequency.

Most popular intervention types in "Grossmont Center For Clinical Research" are "Drug" (36 trials), "Biological" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Atogepant" (3 trials), "Metronidazole" (2 trials), "Placebo-matching Ubrogepant" (2 trials) and "Rimegepant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Grossmont Center For Clinical Research" are 27 trials for "All" genders and 15 trials for "Female" genders.

Currently, there are NaN active trials in "Grossmont Center For Clinical Research". undefined are not yet recruiting, 8 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Grossmont Center For Clinical Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Grossmont Center For Clinical Research, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".